±±Ê¦´óϸ°ûÉúÎïѧ£º e%M;?0j
Ò»¡¢ Ãû´Ê½âÊÍ£º 9=tIz
1£® ͬԴºÐ£¨homeobox£©£¨96¡¢99¡¢91£© j;r-
NCBnz
2£® PCR£¨96£© M3y NAN
3£® ·ºËØ£¨ubquitin£©£¨96£© . Efk*
4£® °é·Ö×Ó£¨chapron£©£¨96£© Tidn-2L73O
5£® ת¼Òò×Ó£¨trascription factor£©£¨96£© %;'s4ly
6£® DG£IP3£¨96£© T::85
7£® »ùÒòÇóý£*****ene knock out£©£¨96¡¢00£© n@i HFBb
8£® ΢¹Ü×éÖ¯ÖÐÐÄ£¨MTOC£©£¨96¡¢01£© B$K=\6o
9£® ¶ËÁ£Ã¸£¨telomerase£©£¨96£© (t|Zn@uY
10£® µ°°×·ÖÑ¡£¨protein sorting£©£¨96¡¢99¡¢00£© 33q}CzK
11£® Transformation£¨92£© _H%c;z+
12£® TransfectionתȾ£¨92£© HC8e>kP9b
13£® Transcytosis×ªÒÆ×÷Óã¨92£© !.gIHY
14£® Transductionתµ¼£¨92£©
(ZizuHC
15£® Transdetermination£¨92£© RqrdAkg
16£® Transdifferentiation£¨92£© x9g#<2w8
17£® Transgenic animalת»ùÒò¶¯Î92£© cT,sh~-x,
18£® Rb£1£¨92£© Fxz
"DZY6
19£® P53£¨92¡¢91£© y%T_pTcU
20£® C£jun£¨92£© \2$|Ei7
21£® ΢¹Û½áºÏµ°°×MAPS£¨99¡¢91£© VA5xp]
22£® °ûÄÚÌ壨99£© Hn"RH1Zy
23£® Cyclin dependent kinase inhibitor(CDKI)(99) 6{b>p+U
24£® G£protein£¨91£© yf+)6D -9n
25£® Restriction point£¨91£© 0h_|t-9j
26£® Antipost£¨91£© i.m^/0!
27£® Capping£¨91£© ,O(hMI85]
28£® TATAbox£¨91£© HZge!Yp<
29£® cDNA library£¨90£© }7Q% 6&IR
30£® Aritotic apparatus£¨90£© y)@wjH{6
31£® ¿çĤÐźŠtransmembrane signal£¨90£© o+'6`g'8
32£® ´ÙÓÐË¿·ÖÁÑÔ mitogen£¨90£© (<9u-HF#
33£® Nuclear lamina£¨90£© [W&T(%(W-
34£® ϸ°ûµòÍö£¨apotosis£©£¨00£© ?@86P|19
35£® ϸ°ûÍâ»ùÖÊ£¨00¡¢01£© g7H(PF?
36£® ϸ°û·Ö»¯£¨00£© /N{*"s
2)
37£® ϸ°ûÐźÅתµ¼£¨signal transduction£©£¨00£© ygcm|PrS
38£® ¿Ë¡£¨00£© 9.#<b|g
39£® »ùÒò×飨00£© QXK{bxwC
40£® Caspase£¨00£© 2,b$7xaf
41£® ת¼Òò×Ó£¨00£© $&c*'3
42£® ÅßÌ¥¸Éϸ°û£¨01£© yG{TH0tq
43£® ¼¤¹â¹²¾Û½¹ÏÔ΢¾µ£¨01£© F== p<lrs
44£® DNAоƬ£¨01£© !N^@4*
¶þ¡¢ ÎÊ´ðÌ⣺ "{t$nVJ
1£® ÊÔÊöÀÒ°±Ëáµ°°×¼¤Ã¸ÊÜÌåµÄÐźÅͨ·£¨96£© SpBy3wd
2£® ÊÔ¾ÙÀý˵Ã÷ÐÅʹϵͳÖÐÓëϸ°ûÔöÖ³Óйصļ¤Ã¸¼°Æä¹¦ÄÜ£¨95£© -9?]IIVb
3£® ÊÔ·ÖÎöÐźÅתµ¼£¨transduction£©µÄ¼¸Ìõͨ·µÄ¹²ÐÔÓëÌØÐÔ£¨92£© <P<z N~i9j
4£® µ°°×ÖʵÄÁ×ËữÓëÈ¥Á×ËữÔÚϸ°ûÐźÅϵͳ´«µ¼ÖеÄ×÷Óã¨93¡¢99£© c+ie8Q!
5£® ÊÔÊöÁ×õ¥Ë®½âøC£¨PLC£©µÄ·ÖÀ༰ÔÚϸ°ûÐźÅתµ¼ÖеÄ×÷Óᣣ¨01£© yHaGkm
6£® ÊÔÊöϸ°û½ÓÊÜ»¯Ñ§Ðźźóµ÷½Ú»ùÒò±í´ïµÄ;¾¶£¨94£© !4!~Lk=
7£® ÊÔÊöϸ°ûÖÜÆÚ¸÷½×¶ÎÖÐCyclins£CdksµÄµ÷¿Ø×÷Óã¨96£© DY*N|OnqJ
8£® ¾ÙÀý˵Ã÷CKIÔÚϸ°ûÔöÖ³µ÷¿ØÖеÄ×÷Óã¨96£© %C]>9."
9£® ÏêÊöcyclins£cdksϵͳÔÚϸ°ûÖÜÆÚG2/M¼°M/G1¹ý¶ÈÖÐÈçºÎÊܵ½µ÷¿ØµÄ£¿ÒÑÖªÄÇЩ·Ö×Ó¿ÉÄÜÊÇcdksµÄµ×Îï¼°ÆäÔÚÁ×ËữÓëÈ¥Á×Ëữ¹ý³ÌÖжÔϸ°û½á¹¹Ó빦Äܱ仯µÄÓ°Ï죨95£© 7
tp36 TE
10£® Cdc2ºÍcyclin»ùÒò£¨cdc13£©ÈçºÎµ÷¿ØÏ¸°ûÖÜÆÚÔËתµÄÏÖ´ú¸ÅÄ92¡¢94£© P+}h$_x
11£® Ϊʲô˵µ°°×ÖÊÁ×Ëữ£È¥Á×ËữºÍ·ºËؽ鵼µÄµ°°×ÖÊË®½â£¨UPP£©µÄ»¥Ïàе÷ÍÆ¶¯Ï¸°ûÖÜÆÚµÄÔËת£¿£¨01£© zbiL P83
12£® ϸ°ûÔöÖ³µ÷¿ØµÄ·Ö×Ó»úÖÆ£¨00£© /dHF6yW
13£® ϸ°û¹Ç¼ÜÔÚϸ°ûÔöÖ³ÖÜÆÚÖеÄ×÷Óã¨00£© e3\T)x&=
14£® P34cdc2µÄÐÔÖʼ°Æä×÷Óõ×ÎïÊÇʲô£¿½«ÒýÆðºÎÖÖЧӦ£¿£¨91£© k5)om;.w
15£® ϸ°ûÓÐË¿·ÖÁÑÖзĴ¸Ìå΢¹ÜµÄ¶¯Á¦Ñ§±ä»¯»úÀí¼°ÆäÓëȾɫÌåÔ˶¯µÄ¹ØÏµ£¨95£© /9X7A;O
16£® ΢¹ÜµÄ×é×°ÓëÈ¥×é×°ÔÚϸ°ûÓÐË¿·ÖÁѹý³ÌÖеĶ¯Ì¬±ä»¯¼°Æä×÷Óã¨92£© b.938#3,
17£® ϸ°ûÓÐË¿·ÖÁѹý³ÌÖзĴ¸ÌåµÄ×é×°ÓëÈ¥×é×°µÄ¶¯Ì¬±ä»¯¼°Æä¹¦ÄÜ£¨93£© dh\P4
18£® ϸ°ûÓÐË¿·ÖÁѺóÆÚȾɫÌå·ÖÀëÇ÷ÏòÁ½¼«µÄ»úÀíÊÇÈçºÎÖ¤Ã÷µÄ£¿£¨90£© mE[y SrV
19£® ÊÔÊöÖÐÐÄÁ£/¶¯Á£È¥ÔÚϸ°ûÓÐË¿·ÖÁÑÖеÄ×÷Óã¨99£© X8\GzNE~R
20£® KinetochoreÊÇÓÉÄļ¸ÖÖÖ÷Òªµ°°××é³É£¬ÓÃʲô·½·¨Ñо¿Æä¶¨Î»¡¢·Ö×ÓÁ¿¼°»úÄÜ£¿£¨90£© 2mU.7!g)
21£® ÊÔ·Ö±ðÐðÊöÈËÀà×ÅË¿Á£ºÍ¶¯Á£µÄ»ù±¾×é³É¼«ÆäĿǰËùÖªµÄ¹¦ÄÜ£¨01£© 5V-I1B&
22£® ÊÔÊöϸ°û±à³ÌÐÔËÀÍö£¨programmed cell death£©ºÍϸ°ûµòÍö£¨apoptosis£©µÄÌØÕ÷ºÍÉúÀíѧÒâÒå¼°Æä¿ÉÄܵĻùÒòµ÷¿Ø£¬ÄãÈÏΪÑо¿µÄÖØµãÓ¦·ÅÔں䦣¿ÎªÊ²Ã´£¿£¨95£© AXB7oV,xt
23£® ApoptosisÓëneerosisµÄ¼ì²âÓëÇø±ð£¨99£© ?7A>+EY
24£® ÈçºÎ¼ø±ðϸ°ûµòÍöÓ뻵ËÀ¡£Ï¸°ûµòÍöÑо¿µÄÖØÒªÒâÒåÊÇʲô£¿£¨01£© +ge?w#R
25£® ÊÔÊöunipintin£proteasen proteolytic system£¨99£© Xa&kIq}(g
26£® ÒÑÖªÓÐÄÇЩÖ÷ÒªµÄ°©»ùÒòÓëÒÖ°©»ùÒòÓëϸ°ûÖÜÆÚµÄµ÷¿ØÓйأ¿²¢¾ÙÀý˵Ã÷£¨93£© 7 8,n%=nG
27£® Oncogene¼°Æä²úÎïÓëϸ°ûÔöÖ³µÄ¹ØÏµ£¨91£© naNghGQ
28£® ¾ÙÀý˵Ã÷oncogene¡¢growth factors¼°ÊÜÌåÖ®¼äµÄÁªÏµ£¨90£© y`Z\N
29£® ÊÔÊöºáÎÆ¼¡¡¢Ï¸°ûÄÚ´Öϸ˿Á½·Ö×ӵĽṹ¡¢¸÷ÖÖÖ÷Òªµ°°×³É·ÖÔÚ¼¡ÈâÊÕËõÖеÄ×÷Óᣣ¨90£© A@'OJRc
30£® ÊÔÊöϸ°ûÖÊÃþÉÏĤµ°°×µÄ¼¸ÖÖÀàÐͼ°Æä¹¦ÄÜ£¨95£© A%vbhD2;W
31£® ÊÔÊöÃâÒßѧ¼¼ÊõÔÚϸ°ûÉúÎïѧÑо¿ÖеÄÓ¦Óã¨92£© Nboaf
32£® ͬԴºÐµÄ·¢ÏÖ¼°ÆäÔÚÉúÎïÖеÄÖØÒªÒâÒ壨92£© \7_y%HR
33£® ÈçÒÑ֪ijһ»ùÒòƬ¶ÎÐòÁкÍÒÑ»ñµÃijһµ¥¿Ë¡¿¹ÌåÓ¦ÓúÎÖÖ¼¼Êõ·Ïߵõ½ËüµÄcDNA¿Ë¡£¨94£© "M0z(NkH
34£® ¾ÙÀý˵Ã÷ÃâÒßÓ«¹âFISH¡¢ÃâÒߵ羵ÖîÏî¼¼ÊõµÄ»ù±¾ÔÀí¼°ÆäÔÚϸ°ûÉúÎïѧÑо¿Öеĸ÷½â¾öʲôÎÊÌ⣨94£© @F>D+=hS
35£® ÄãµÄ˶ʿÂÛÎÄÌá³öÁËʲôÎÊÌ⣿ÈçºÎ½â¾öµÄ£¿½áÂÛÊÇʲô£¿£¨96¡¢94¡¢00£©